PubRank

J Taranger

Author PubWeight™ 67.60‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A toxoid vaccine for pertussis as well as diphtheria? Lessons to be relearned. Lancet 1996 4.30
2 Scandinavian model for eliminating measles, mumps, and rubella. Br Med J (Clin Res Ed) 1984 3.25
3 A placebo-controlled trial of a pertussis-toxoid vaccine. N Engl J Med 1995 1.78
4 Vaccination programme for eradication of measles, mumps, and rubella. Lancet 1982 1.74
5 Evaluation of PCR for diagnosis of Bordetella pertussis and Bordetella parapertussis infections. J Clin Microbiol 1998 1.68
6 History of whooping cough in nonvaccinated Swedish children, related to serum antibodies to pertussis toxin and filamentous hemagglutinin. J Pediatr 1990 1.53
7 Maturation indicators and the pubertal growth spurt. Am J Orthod 1982 1.53
8 Parapertussis infection followed by pertussis infection. Lancet 1994 1.49
9 Protective levels of serum antibodies stimulated in infants by two injections of Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugate. J Pediatr 1989 1.46
10 Height and height velocity in early, average and late maturers followed to the age of 25: a prospective longitudinal study of Swedish urban children from birth to adulthood. Ann Hum Biol 1991 1.44
11 Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis. Clin Infect Dis 1999 1.39
12 Clinical and immunologic responses to the capsular polysaccharide of Haemophilus influenzae type b alone or conjugated to tetanus toxoid in 18- to 23-month-old children. J Pediatr 1988 1.14
13 Skeletal stages of the hand and wrist as indicators of the pubertal growth spurt. Acta Odontol Scand 1980 1.13
14 Haemophilus influenzae meningitis in Sweden 1981-1983. Arch Dis Child 1987 1.13
15 The somatic development of children in a swedish urban community. Acta Paediatr Scand Suppl 1976 1.13
16 Swedish experience of two dose vaccination programme aiming at eliminating measles, mumps, and rubella. Br Med J (Clin Res Ed) 1987 1.12
17 VI. Somatic pubertal development. Acta Paediatr Scand Suppl 1976 1.10
18 Acquisition of IgG serum antibodies against two Bordetella antigens (filamentous hemagglutinin and pertactin) in children with no symptoms of pertussis. Pediatr Infect Dis J 1995 1.08
19 Efficacy of a monocomponent pertussis toxoid vaccine after household exposure to pertussis. J Pediatr 1997 1.08
20 Environmental contamination leading to false-positive polymerase chain reaction for pertussis. Pediatr Infect Dis J 1994 1.06
21 I. physical growth from birth to 16 years and longitudinal outcome of the study during the same age period. Acta Paediatr Scand Suppl 1976 1.03
22 Long-term treatment with corticosteroids/ACTH in asthmatic children. IV. Skeletal maturation. Acta Paediatr Scand 1986 1.00
23 Menarche and voice change as indicators of the pubertal growth spurt. Acta Odontol Scand 1980 1.00
24 Antibody response to pertussis toxin in patients with clinical pertussis measured by enzyme-linked immunosorbent assay. Eur J Clin Microbiol Infect Dis 1988 0.98
25 Dental development, dental age and tooth counts. Angle Orthod 1985 0.97
26 Parapertussis and pertussis: differences and similarities in incidence, clinical course, and antibody responses. Int J Infect Dis 1999 0.95
27 Response and decline of serum IgG antibodies to pertussis toxin, filamentous hemagglutinin and pertactin in children with pertussis. Scand J Infect Dis 1995 0.94
28 Serum antibody response to filamentous hemagglutinin in patients with clinical pertussis measured by an enzyme-linked immunosorbent assay. Eur J Clin Microbiol Infect Dis 1988 0.92
29 Toxin-neutralizing antibodies in patients with pertussis, as determined by an assay using Chinese hamster ovary cells. J Infect Dis 1988 0.92
30 Mass vaccination programme aimed at eradicating measles, mumps and rubella in Sweden: vaccination of schoolchildren. Vaccine 1985 0.91
31 Immunization of children with pertussis toxoid decreases spread of pertussis within the family. Pediatr Infect Dis J 1998 0.90
32 Persistence of serum antibodies elicited by Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infants vaccinated at 3, 5 and 12 months of age. Pediatr Infect Dis J 1991 0.90
33 Estimating incidence of whooping cough over time: a cross-sectional recall study of four Swedish birth cohorts. Int J Epidemiol 1989 0.90
34 How common is whooping cough in a nonvaccinating country? Pediatr Infect Dis J 1993 0.89
35 Duration of serum antibodies elicited by Haemophilus influenzae type b capsular polysaccharide alone or conjugated to tetanus toxoid in 18- to 23-month-old children. J Pediatr 1990 0.88
36 Pubertal growth and maturity pattern in early and late maturers. A prospective longitudinal study of Swedish urban children. Swed Dent J 1992 0.87
37 Determination of neutralizing antibodies and specific immunoglobulin isotype levels in infants after vaccination against diphtheria. Eur J Clin Microbiol Infect Dis 1992 0.86
38 Sensitivity to sensitins and tuberculin in Swedish children. II. A study of preschool children. Tubercle 1991 0.86
39 [Rifampicin and liver function (72 punctures biopsies)]. Rev Tuberc Pneumol (Paris) 1971 0.85
40 Serum immunoglobulin G antibody responses to Bordetella pertussis lipooligosaccharide and B. parapertussis lipopolysaccharide in children with pertussis and parapertussis. Clin Diagn Lab Immunol 2001 0.83
41 Influence of high titers of maternal antibody on the serologic response of infants to diphtheria vaccination at three, five and twelve months of age. Pediatr Infect Dis J 1995 0.83
42 Serum antibodies in six-year-old children vaccinated in infancy with a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine. Pediatr Infect Dis J 1996 0.82
43 Mild clinical course of pertussis in Swedish infants of today. Lancet 1982 0.81
44 Unequal mitotic sister chromatid exchange and different length of Y chromosomes. Hum Genet 1985 0.80
45 II. evaluation of biological maturation by means of maturity criteria. Acta Paediatr Scand Suppl 1976 0.79
46 Determination of pertactin IgG antibodies for the diagnosis of pertussis. Clin Microbiol Infect 2003 0.79
47 Primum non nocere: a pharmacologically inert pertussis toxoid alone should be the next pertussis vaccine. Pediatr Infect Dis J 1993 0.79
48 Screening for congenital hypothyroidism in the newborn. Lancet 1973 0.78
49 Timing of tooth emergence. A prospective longitudinal study of Swedish urban children from birth to 18 years. Swed Dent J 1986 0.77
50 III. dental development from birth to 16 years. Acta Paediatr Scand Suppl 1976 0.77
51 The timing and duration of adolescent growth. Acta Odontol Scand 1980 0.77
52 Avidity and titers of the antibody response to two inactivated poliovirus vaccines with different antigen content. Acta Paediatr 1993 0.77
53 Immunogenicity and reactogenicity of diphtheria, tetanus and pertussis toxoids combined with inactivated polio vaccine, when administered concomitantly with or as a diluent for a Hib conjugate vaccine. Vaccine 2001 0.77
54 Serum antibodies against a 69-kilodalton outer-membrane protein, pertactin, from Bordetella pertussis in nonvaccinated children with and without a history of clinical pertussis. J Pediatr 1992 0.77
55 V. a new method for the assessment of skeletal maturity- the mat- method (mean appearance time of bone stages). Acta Paediatr Scand Suppl 1976 0.77
56 Hepatitis B carriers in Sweden--effects of immigration. Scand J Infect Dis 1993 0.76
57 Safety, immunogenicity and an open, retrospective study of efficacy of a monocomponent pertussis toxoid vaccine in infants. Pediatr Infect Dis J 1994 0.76
58 Immunogenicity and safety of a pertussis vaccine composed of pertussis toxin inactivated by hydrogen peroxide, in 18- to 23-month-old children. J Pediatr 1990 0.76
59 Dental emergence stages and the pubertal growth spurt. Acta Odontol Scand 1981 0.76
60 Standardization of acellular pertussis vaccine by assay of serum neutralizing antibodies to pertussis toxin (antitoxin): analogy with diphtheria toxoid. Dev Biol Stand 1998 0.76
61 On observer errors in pertussis vaccine studies. Pediatr Infect Dis J 1997 0.75
62 Increasing the uptake of rubella immunisation. Br Med J (Clin Res Ed) 1985 0.75
63 No cross-reactivity with filamentous hemagglutinin of Bordetella pertussis in sera from patients with nontypable Haemophilus influenzae pneumonia. Pediatr Infect Dis J 1996 0.75
64 Towards better pertussis vaccines. Ann Med 1997 0.75
65 [Hepatic coma caused by a rifampicin overdosage]. Mars Med 1970 0.75
66 [Bronchography with Hytrast]. Rev Tuberc Pneumol (Paris) 1966 0.75
67 Intrauterine varicella: a report of two cases associated with hyper-A-immunoglobulinemia. Scand J Infect Dis 1981 0.75
68 Antibody levels to pertussis toxin in preschool children in a non-vaccinating country (Sweden). Ann Sclavo Collana Monogr 1986 0.75
69 [Bacteriological efficacy of the treatment with Rifampicin (57 cases)]. Mars Med 1970 0.75
70 [Diagnostic signs and treatment of pulmonary suppuration]. Mars Med 1968 0.75
71 [Prevention and treatment of intestinal dysmicrobialism with a new molecule]. Therapeutique 1971 0.75
72 Comparison of the knowledge of students at the beginning and end of a course in paediatrics. Br J Med Educ 1973 0.75
73 [Calcitherapy and long-term corticoids]. Mars Med 1971 0.75
74 [Pertussis vaccine with a component--safe and effective]. Lakartidningen 1997 0.75
75 [Statistical study of the effect of a bronchial liquifier in chronic bronchorrhea]. Mars Med 1972 0.75
76 [Growth diagrams for height, weight and head circumference from birth to the age of 18 years]. Lakartidningen 1973 0.75
77 [Treatment of respiratory infections with Metampicillin]. Mars Med 1972 0.75
78 [National cooperation in mass vaccination of infants is important]. Lakartidningen 1993 0.75
79 [The treatment of purulent bronchorrhea]. Mars Med 1970 0.75
80 [Comparative study (tolerance and effectiveness) of classic antituberculous therapy (P.A.S.-streptomycin-isoniazid) and a new combination (prothionamide-streptomycin-isoniazid)]. Mars Med 1969 0.75
81 [Management of antibiotic therapy in chronic bronchitis]. Sem Hop 1970 0.75
82 [General vaccination against Haemophilus influenzae type b--unified decision for the entire country is needed]. Lakartidningen 1992 0.75
83 [Selective spectrum antibiotic therapy and chronic bronchitis]. Bronches 1975 0.75
84 Immunity to pertussis. Not all virulence factors are protective antigens. Adv Exp Med Biol 1998 0.75
85 [Pediatrics in an underdeveloped land. 2. Effective sick care despite limited resources]. Lakartidningen 1968 0.75
86 [Mercury-induced hypersensitivity rare after subcutaneous injection of vaccines]. Lakartidningen 1990 0.75
87 VII. graphic analysis of biological maturation by means of maturograms. Acta Paediatr Scand Suppl 1976 0.75
88 [How can one evaluate what the medical student has learned?]. Lakartidningen 1971 0.75
89 The Gothenburg pertussis vaccine study. Dev Biol Stand 1997 0.75
90 [The low number of reported adverse effects after vaccination against measles, mumps, rubella]. Lakartidningen 1987 0.75
91 [Treatment of purulent bronchorrhea]. Mars Med 1969 0.75
92 [A method for assessing sex characteristics during puberty]. Lakartidningen 1973 0.75
93 [Children of immigrants--a handicap problem (3): the language--the big problem of the hospital]. Lakartidningen 1970 0.75
94 [Whooping cough and whooping cough vaccination - a dilemma of the vaccination policy]. Lakartidningen 1982 0.75
95 [Three doses of pertussis vaccine should be recommended as a start]. Lakartidningen 1997 0.75
96 Pertussis in infancy does not increase the risk of asthma. Pediatrics 1998 0.75
97 Dental development assessed by tooth counts and its correlation to somatic development during puberty. Eur J Orthod 1984 0.75
98 [Treatment of pulmonary tuberculosis with Isoxyl (bacteriological considerations)]. Rev Tuberc Pneumol (Paris) 1967 0.75
99 IV. skeletal development from birth to 7 years. Acta Paediatr Scand Suppl 1976 0.75
100 Examination of similarities between diphtheria and pertussis and their toxoids provide insight into vaccine-induced protection to Bordetella pertussis. Dev Biol Stand 1997 0.75
101 [Apropos of a case of primary diffuse pulmonary fibrosis]. J Fr Med Chir Thorac 1966 0.75
102 The timing of secondary sex characters and their relationship to the pubertal maximum of linear growth in girls. Swed Dent J 1991 0.75
103 [A debate on pertussis vaccines. The monocomponent vaccine has many advantages]. Lakartidningen 1996 0.75
104 [Rifomycin in local treatments of tuberculosis]. Mars Med 1966 0.75
105 ["Primary" resistance and social milieu]. Rev Tuberc Pneumol (Paris) 1966 0.75
106 [The 1969-70 influenza epidemic in Marseilles. Clinical survey in an adult medical department]. Mars Med 1970 0.75
107 [Rifampicin and hepatic puncture biopsy]. Mars Med 1970 0.75
108 Immunologic evaluation of a pertussis toxoid vaccine. Dev Biol Stand 1991 0.75
109 Hypotonic hyporesponsive episodes in eight pertussis vaccine studies. Dev Biol Stand 1997 0.75
110 [Limited epidemic of tuberculosis around a contaminator]. Mars Med 1971 0.75
111 [Haemophilus influenza and chronic bronchitis. Our experience of the last 3 years (1970-1973)]. Bronches 1975 0.75
112 [Directed antibiotic therapy of chronic bronchitis]. Therapeutique 1970 0.75
113 [Risk of asperigillosis in pulmonary tuberculosis (apropos of 7 cases)]. Mars Med 1967 0.75
114 [Current incidence of primary resistance in hospitals]. Mars Med 1972 0.75
115 [Hypersmolar diabetic coma (apropos of a case)]. Mars Med 1970 0.75
116 [Frequency of primary resistance of the Koch bacillus]. Mars Med 1967 0.75
117 [Diagnosis of tuberculous pleurisy. Importance of needle-biopsy of the pleura and culture of the fragment (computer study)]. Rev Tuberc Pneumol (Paris) 1971 0.75
118 Pertussis, pertussis vaccination and postnatal aetiology of cerebral palsy in Western Australia. Dev Med Child Neurol 1983 0.75
119 [Increased frequency of sudden infant death in spite of whooping cough vaccination]. Lakartidningen 1992 0.75